Skip to main content

Providing independent clinical excellence since 2005

The SCVC Blog

Cardiovascular care news and articles from our expert team

Metabolic Health Assessment

Is is increasingly obvious that not everyone with raised coronary inflammation and elevated risk of heart attack simply has a raised LDL Cholesterol- in fact there appears to be a mixed bag of risk factors associated with high coronary artery inflammation, including raised LDL, raised LP (a), raised Homocysteine, hypertension and dysregulated glucose.   Our metabolic health assessment is therefore designed to offer a comprehensive dive into known contributory causes, the latest and most controversial of which is 'glucose dysregulation', the principle topic of this article.

What are the latest guidelines target for LDL?

For patients who have been diagnosed with an acute coronary syndrome, requiring bypass surgery or stent, or have CT Angiography and or raised FAI, the latest European and UK guidelines reflect the finding that there is no lower limit for LDL yet discovered, basically meaning the lower the better. These recommendations come after new trials with lower targets showed better outcomes. As a result, millions of people around the world need to be looking more carefully at whether they are taking sufficient medication to lower their LDL to these new targets, for the very best outcomes to be achieved.

So what does determine your LDL (‘bad’) Cholesterol?

Statins are a mind boggling biological 'ruse'. When this medication is taken orally, it causes liver cells to become deficient in essential cholesterol, so they respond by increasing the number of cell surface LDL receptors, thereby enhancing their capacity to extract LDL particles from the blood, significantly lowering circulating LDL levels. Statins remain the most effective and well-known way that doctors can lower LDL levels to prevent or treat coronary heart disease.

Five Reasons Why a Cardiologist Might Recommend a Continuous Glucose Monitor (CGMs) to their Patient

Continuous glucose monitoring offers a valuable tool for anyone concerned with their long-term health, especially those with a family history of diabetes or other cardiovascular risk factors. Whether through self-monitoring or professional analysis such as our metabolic health assessment, CGMs can provide actionable insights that help individuals manage their glucose levels more effectively, ultimately contributing to a healthier, longer life. By understanding and managing your glucotype, optimising your diet and exercise, and taking steps to prevent prediabetes and diabetes, you can potentially avoid serious health conditions in the future.